Interactive Brokers shares jump as it secures spot in S&P 500
Quantum-Si Inc (NASDAQ:QSI), a company currently valued at $271.6 million and trading with high price volatility according to InvestingPro data, saw its President and CEO Jeffrey Alan Hawkins (NASDAQ:HWKN) recently sell 23,707 shares of the company. The transaction, disclosed in a regulatory filing, was executed at a weighted average price of approximately $1.3855 per share, with prices ranging from $1.36 to $1.405. The total value of the shares sold amounted to $32,846. This sale was conducted under a mandatory sell-to-cover provision to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units. Following the transaction, Hawkins retains direct ownership of 2,646,716 shares of Quantum-Si. The stock has experienced significant movement recently, with a -10.3% return over the past week but an impressive 58.2% gain over the last six months. InvestingPro analysis shows the company maintains a strong liquidity position with a current ratio of 11.99, though it’s currently not profitable. For deeper insights into QSI’s financial health and growth prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, QuantumSi Inc. reported its fourth-quarter 2024 earnings, showing a larger-than-expected loss per share and revenue that fell short of projections. The company posted an actual EPS of -$0.23, missing the forecast of -$0.19, and reported revenue of $1.2 million, below the expected $1.79 million. Despite this, QuantumSi demonstrated significant revenue growth, with a 52% increase from the previous quarter and a 183% rise for the full year compared to 2023. Additionally, the company launched a new product, Platinum Pro, in January 2025 and plans to launch its Proteus platform in the second half of 2026. QuantumSi has also raised $50 million in January 2025, adding to its cash reserves of $209.6 million. Analysts from Canaccord Genuity and H.C. Wainwright engaged with the company during its earnings call, discussing sales cycles and market opportunities. The company continues to focus on its innovation roadmap, with expectations to launch a Version 4 Sequencing Kit in the third quarter of 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.